Price target
38.500.00 0.00%
The 4 analysts offering 1 year price forecasts for URGN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to URGN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
URGN EPS for the last quarter is −0.72 USD despite the estimation of −0.68 USD. In the next quarter EPS is expected to reach −0.87 USD. Track more of UroGen Pharma Ltd. financials and stay on top of what is up with the company.
In the next quarter UroGen Pharma Ltd. revenue is expected to reach 21.39 M USD. Check out UroGen Pharma Ltd. revenue and earnings and make informed decisions.
According to analysts, URGN price target is 38.50 USD with a max estimate of 54.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with URGN news and stock market news.
We've gathered opinions of 5 analysts rating URGN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.